Castration-resistant prostate cancer cells are dependent on the high activity of CDK7

被引：0
|
作者：
Satu Pallasaho
Aishwarya Gondane
Anni Kuivalainen
Samuel Girmay
Siver Moestue
Massimo Loda
Harri M. Itkonen
机构：
[1] University of Helsinki,Department of Biochemistry and Developmental Biology, Faculty of Medicine
[2] NTNU,Department of Clinical and Molecular Medicine
[3] Nord University,Department of Pharmacy
[4] Weill Cornell Medicine,Department of Pathology and Laboratory Medicine
[5] New York-Presbyterian Hospital,undefined
[6] The Broad Institute of Harvard and MIT,undefined
[7] The New York Genome Center,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词：
Cyclin-dependent kinase 7; Castration-resistant prostate cancer; O-GlcNAc transferase; Cyclin-dependent kinase 9;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5255 / 5263
页数：8
相关论文
共 50 条
  • [41] Biomarkers in Metastatic Castration-resistant Prostate Cancer
    Miller, K.
    AKTUELLE UROLOGIE, 2015, 46 (01) : 66 - 70
  • [42] Olaparib in metastatic castration-resistant Prostate Cancer
    Lorenz, Judith
    AKTUELLE UROLOGIE, 2022, 53 (02)
  • [43] Castration-Resistant Prostate Cancer: AUA Guideline
    Cookson, Michael S.
    Roth, Bruce J.
    Dahm, Philipp
    Engstrom, Christine
    Freedland, Stephen J.
    Hussain, Maha
    Lin, Daniel W.
    Lowrance, William T.
    Murad, Mohammad Hassan
    Oh, William K.
    Penson, David F.
    Kibel, Adam S.
    JOURNAL OF UROLOGY, 2013, 190 (02): : 429 - 438
  • [44] Enzalutamide in Castration-Resistant Prostate Cancer Reply
    Hussain, Maha
    Saad, Fred
    Sternberg, Cora N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (14): : 1381 - 1381
  • [45] Dexamethasone potentiates the antiangiogenic activity of docetaxel in castration-resistant prostate cancer
    Wilson, C.
    Scullin, P.
    Worthington, J.
    Seaton, A.
    Maxwell, P.
    O'Rourke, D.
    Johnston, P. G.
    McKeown, S. R.
    Wilson, R. H.
    O'Sullivan, J. M.
    Waugh, D. J. J.
    BRITISH JOURNAL OF CANCER, 2008, 99 (12) : 2054 - 2064
  • [46] Olaparib for Metastatic Castration-Resistant Prostate Cancer
    de Bono, J.
    Mateo, J.
    Fizazi, K.
    Saad, F.
    Shore, N.
    Sandhu, S.
    Chi, K. N.
    Sartor, O.
    Agarwal, N.
    Olmos, D.
    Thiery-Vuillemin, A.
    Twardowski, P.
    Mehra, N.
    Goessl, C.
    Kang, J.
    Burgents, J.
    Wu, W.
    Kohlmann, A.
    Adelman, C. A.
    Hussain, M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (22): : 2091 - 2102
  • [47] Advances in metastatic castration-resistant prostate cancer
    Kentepozidis, Nikolaos
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 : S108 - S108
  • [48] Predicting the future in castration-resistant prostate cancer
    Verhagen, Paul
    LANCET ONCOLOGY, 2009, 10 (03): : 201 - 202
  • [49] Cabazitaxel for the treatment of castration-resistant prostate cancer
    Agarwal, Neeraj
    Sonpavde, Guru
    Sartor, Oliver
    FUTURE ONCOLOGY, 2011, 7 (01) : 15 - 24
  • [50] Novel treatments for castration-resistant prostate cancer
    Sternberg, Cora N.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S195 - S199
12345